ArticleNPJ science of food2026
Isolation and characterization of Lactobacillus plantarum LP2301 from bovine milk: acid and bile tolerance, antibacterial activity, and genomic safety evaluation.
Article in NPJ science of food, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The long-term and non-standard use of antibiotics poses a significant threat to food safety and human health. Probiotics are a promising alternative to antibiotics, effectively combating bacterial infections while reducing the risks associated with antibiotic resistance. Gram staining confirmed LP2301 as a Gram-positive bacterium, and species identification as Lactobacillus plantarum was established by 16S rRNA gene sequencing and whole-genome sequencing. In this study, LP2301 was isolated from the milk of a healthy dairy cow, which exhibits characteristics of acid (pH = 2.5) and 0.3% bile salt tolerance and the ability to secrete effective substances that inhibit the growth of pathogenic bacteria. Through whole-genome sequencing, we identified plantaricin biosynthetic gene clusters (including plnE and plnF) and the absence of hemolytic ability in LP2301. Combined experimental and genomic evidence suggests that the antimicrobial activity is attributable to bacteriocins, particularly plantaricin-related peptides, and Proteinase K treatment experiment confirmed the presence of proteinaceous bacteriocin-like substances contributing to antimicrobial activity. However, the specific effective components require further experimental verification. These findings suggest that LP2301 has potential as a natural antimicrobial agent and a candidate for further evaluation as an antibiotic alternative, pending in vivo validation.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.